Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1967 of 6351
-
Can a treadmill plus brain games help stroke patients walk again?
Symptom relief OngoingIn this research study, the investigators aim to test the usability and efficacy of the GaitBetter system for gait rehabilitation after stroke.
Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New drug combo shows promise for rare salivary gland cancer
Disease control OngoingThis phase II trial studies the effect of pemetrexed and pembrolizumab in treating patients with salivary gland cancer that has come back (recurrent) and/or has spread to other places in the body (metastatic). Chemotherapy drugs, such as pemetrexed, work in different ways to stop…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
AI reads brain scans to spot Parkinson's lookalikes
Diagnosis OngoingThe purpose of this study is to test the performance of the AID-P across 21 sites in the Parkinson Study Group. Each site will perform imaging, clinical scales, diagnosis, and will upload the data to the web-based software tool. The clinical diagnosis will be blinded to the diagn…
Sponsor: University of Florida • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC
-
New catheter aims to tame irregular heartbeat
Disease control Recruiting nowA prospective, single-arm, single-center study to evaluate the safety, performance, and effectiveness of the SpherePVI™ Catheter for treating paroxysmal AF.
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Teen kidney transplant patients may get a better drug option
Disease control Recruiting nowThe purpose of this study is to evaluate the benefits and risks of conversion of existing adolescent kidney allograft recipients aged 12 to less than 18 years of age to a belatacept-based immunosuppressive regimen as compared to continuation of a calcineurin inhibitor-based regim…
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug cocktail aims to stall pancreatic cancer
Disease control OngoingThis phase II trial studies the effects of lenvatinib and pembrolizumab maintenance therapy in treating patients with pancreatic cancer that has spread to other places in the body (advanced) and cannot be removed by surgery (unresectable). Lenvatinib may stop the growth of tumor …
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New hope for chinese patients with spinal arthritis: phase 3 drug trial shows promise
Disease control CompletedThe purpose of this study was to evaluate the efficacy, safety, and tolerability of secukinumab in Chinese patients with active non-radiographic axial spondyloarthritis (nr-axSpA).
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for bone sarcoma: regorafenib maintenance trial launches
Disease control Recruiting nowThis is a multicenter phase II study concerning patients with high-grade bone sarcoma (HGBS) without complete remission after standard treatment at diagnosis or at relapse. Patients will be treated with regorafenib + best supportive care (BSC) for a maximum of 12 months as maint…
Phase 2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Brain zaps for BPD depression: new hope or hype?
Symptom relief Recruiting nowThis study evaluates the antidepressant effects of an accelerated schedule of theta-burst stimulation, termed accelerated intermittent theta-burst stimulation (aiTBS), in individuals with borderline personality disorder (BPD) or trait and comorbid mood depressive disorder (MDD) o…
Sponsor: Stanford University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Text messages and clinic prompts may boost smoking cessation
Disease control CompletedThis trial aims to connect tobacco using patients of Community Health Centers (CHCs) and Federally Qualified Health Centers (FQHCs) with evidence-based treatment to help them quit. The trial will evaluate multiple strategies, that target both clinics and for patients, to increase…
Sponsor: University of Utah • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a single dose of a new drug boost depression relief?
Disease control CompletedThis study is open to adults between 18 and 65 years of age who have depression (major depressive disorder). People with a current depressive episode lasting between 2 months and one and a half years can join the study. This study is for people for whom existing treatments for de…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a smartphone app help cancer patients kick the habit?
Disease control OngoingThis phase III trial compares the Quit2Heal smoking cessation smartphone application (app) to the QuitGuide app in helping cancer patients quit smoking. Both apps provide tools to cope with urges to smoke, step-by-step guides for quitting smoking, help in planning for quitting an…
Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New glasses could slow Kids' nearsightedness over 3 years
Disease control OngoingThis is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.
Sponsor: SightGlass Vision, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could an antidepressant help stroke survivors regain speech?
Symptom relief Recruiting nowIn this project, the investigators will investigate the effects of a selective serotonin reuptake inhibitor (SSRI), escitalopram, on augmenting language therapy effectiveness, as measured by naming untrained pictures and describing pictures, in individuals with aphasia in the acu…
Phase 2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New heart valve device offers hope for High-Risk patients
Disease control OngoingInterventional study to evaluate the safety and efficacy of the Medtronic CoreValve™ Evolut™ PRO System when used by China implanting centers in Chinese patients with severe symptomatic aortic stenosis (AS) who are at high risk for Surgical Aortic Valve Replacement (SAVR).
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a weekly shot delay diabetes in cystic fibrosis? new trial launches
Disease control Recruiting nowDiabetes is a major co-morbidity in pancreatic insufficient cystic fibrosis (PI-CF) and associated with worse outcomes. While reduced β-cell mass contributes to the insulin secretory defects that characterizes cystic fibrosis-related diabetes (CFRD), other modifiable determinants…
Phase 2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Dialysis Patients' heart risk: a new prediction model under study
Knowledge-focused CompletedThis prospective, single-center observational cohort study evaluates cardiovascular mortality risk in adults receiving maintenance hemodialysis. During the first year after enrollment, four scheduled assessments are used to characterize demographic factors, dialysis treatment, me…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Genetic detective study aims to solve medical mysteries for 1,000 undiagnosed patients
Knowledge-focused Recruiting nowThe primary purpose of this study is to discover new disease genes for rare Mendelian disorders and its secondary purpose include diagnosing people with rare genetic disorders that have not been previously diagnosed through conventional clinical means, learning more about the pat…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Brain exercises may boost aging minds: new study tests computerized training
Disease control CompletedThis study is a validation study to evaluate efficacy of a neuroplasticity-based, computerized cognitive training program INHANCE (Improving Neurological Health in Aging via Neuroplasticity-based Computerized Exercise) to improve neurological and neuropsychological health in olde…
Sponsor: Posit Science Corporation • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Double-Drug attack on rheumatoid arthritis shows promise in new trial
Disease control OngoingAs stated by the European League Against Rheumatism (EULAR) and the Société Française de Rhumatologie (SFR), treatment of patients with rheumatoid arthritis (RA) should target sustained remission or at least low disease activity. However, despite significant advances based on var…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC